Licensee Uses in Licenses Clause

Licenses from Amended and Restated License Agreement

This FIRST AMENDED AND RESTATED LICENSE AGREEMENT (the Agreement), dated as of September , 2011 (the Execution Date) and effective as of August 13, 2010 (the Effective Date) by and between Symphony Evolution, Inc., a Delaware corporation (Symphony) and Kadmon Corporation, LLC (f/k/a Kadmon Pharmaceuticals, LLC), a Delaware limited liability company (Licensee) (each of Symphony and Licensee being a Party, and collectively, the Parties).

Licenses. Upon termination of this Agreement as a whole, all licenses granted to Licensee hereunder shall terminate. Upon termination of this Agreement with respect to either the Oncology Field or the Non-Oncology Field, CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION all licenses granted to Licensee hereunder shall automatically be deemed to be terminated with respect to the terminated field.

Licenses from Amended and Restated License Agreement

This FIRST AMENDED AND RESTATED LICENSE AGREEMENT (the Agreement), dated as of September , 2011 (the Execution Date) and effective as of August 13, 2010 (the Effective Date) by and between Symphony Evolution, Inc., a Delaware corporation (Symphony) and Kadmon Corporation, LLC (f/k/a Kadmon Pharmaceuticals, LLC), a Delaware limited liability company (Licensee) (each of Symphony and Licensee being a Party, and collectively, the Parties).

Licenses. Upon termination of this Agreement as a whole, all licenses granted to Licensee hereunder shall terminate. Upon termination of this Agreement with respect to either the Oncology Field or the Non-Oncology Field, CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION all licenses granted to Licensee hereunder shall automatically be deemed to be terminated with respect to the terminated field.

Licenses from License Agreement

This LICENSE AGREEMENT (this "Agreement") is made and entered into as of this 3rd day of May, 2010 ("Effective Date") by and between Peregrine Pharmaceuticals, Inc., organized under the laws of Delaware, having its principal place of business at 14282 Franklin Avenue, Tustin, CA 92780 ("Licensor"), and Stason Pharmaceuticals, Inc., organized under the laws of California, having its principal place of business at 11 Morgan, Irvine, California 92618-4327 ("Licensee"). Licensor and Licensee may each be referred to herein individually as a "Party" and collectively as the "Parties."

Licenses. Subject to Section 11.5.4, upon termination of this Agreement, the licenses granted herein shall terminate and the intellectual property rights granted herein shall revert to Licensor, at no cost to Licensor.